Inventor · disambiguated record
Paul E. Persons
Also filed as: PERSONS PAUL E
37 granted patents·2 pending applications·3,778 citations·filing 1991–2009
98Inventor score
Files withSEPRACOR INC15RHONE POULENC RORER PHARMA12AVENTIS PHARMA INC4AVENTIS PHARM PROD INC2AVENTIS PHARMACETICAL PRODUCTS1
Top patents by PatentIndex Score
39 records- 0199US6524347B1Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2000·Granted Feb 25, 2003·307 cites·11 claims
- 0299US6057320ABis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseAVENTIS PHARM PROD INC·Filed 1997·Granted May 2, 2000·148 cites·13 claims
- 0399USRE36256EBis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1997·Granted Jul 20, 1999·183 cites·20 claims
- 0499US5646153ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Jul 8, 1997·259 cites·18 claims
- 0599US5480883ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1993·Granted Jan 2, 1996·383 cites·20 claims
- 0699US5302606AStyryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1991·Granted Apr 12, 1994·284 cites·12 claims
- 0798US5710158AAryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1994·Granted Jan 20, 1998·339 cites·14 claims
- 0897US6159978AQuinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARM PROD INC·Filed 1998·Granted Dec 12, 2000·203 cites·36 claims
- 0997US5721237AProtein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation propertiesRHONE POULENC RORER PHARMA·Filed 1995·Granted Feb 24, 1998·245 cites·13 claims
- 1097US5714493AAryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1994·Granted Feb 3, 1998·176 cites·1 claims
- 1197US5656643ABis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Aug 12, 1997·258 cites·4 claims
- 1297US5409930ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1992·Granted Apr 25, 1995·314 cites·13 claims
- 1396US7294637B2Method of treating addiction or dependence using a ligand for a monamine receptor or transporterSEPRACOR INC·Filed 2004·Granted Nov 13, 2007·89 cites·35 claims
- 1496US6762177B2Spirocyclic ligands for sigma receptors, and libraries and methods of use thereofSEPRACOR INC·Filed 2002·Granted Jul 13, 2004·41 cites·48 claims
- 1595US5795889ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Aug 18, 1998·59 cites·17 claims
- 1693US6645969B1Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinaseAVENTIS PHARMA INC·Filed 1995·Granted Nov 11, 2003·74 cites·12 claims
- 1793USRE37650EAryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinaseAVENTIS PHARMACETICAL PRODUCTS·Filed 1994·Granted Apr 9, 2002·88 cites·5 claims
- 1892US7132551B2Ligands for monoamine receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2003·Granted Nov 7, 2006·45 cites·17 claims
- 1991US6992077B2Spirocyclic ligands for sigma receptors, and libraries and methods of use thereofSEPRACOR INC·Filed 2004·Granted Jan 31, 2006·43 cites·90 claims
- 2091US6846815B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2003·Granted Jan 25, 2005·28 cites·18 claims
- 2191US6476019B1Spirocyclic ligands for sigma receptors, and libraries and methods of use thereofSEPRACOR INC·Filed 2000·Granted Nov 5, 2002·42 cites·117 claims
- 2290US5656655AStyryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinaseRHONE-POULENC INC·Filed 1995·Granted Aug 12, 1997·50 cites·10 claims
- 2388US6699866B2Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2002·Granted Mar 2, 2004·17 cites·23 claims
- 2483US7816375B2Ligands for monoamine receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2009·Granted Oct 19, 2010·4 cites·16 claims
- 2581US6713479B2Piperidine-piperazine ligands for neurotransmitter receptorsSEPRACOR INC·Filed 2002·Granted Mar 30, 2004·8 cites·83 claims
- 2678US7517892B2Ligands for monoamine receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2001·Granted Apr 14, 2009·8 cites·16 claims
- 2777US7511141B2Piperidine-piperazine ligands for neurotransmitter receptorsSEPRACOR INC·Filed 2005·Granted Mar 31, 2009·1 cites·14 claims
- 2876US5677329AStyryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Oct 14, 1997·15 cites·16 claims
- 2972US5418245AStyryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinaseRHONE POULENC RORER INT·Filed 1994·Granted May 23, 1995·12 cites·18 claims
- 3071US6936614B2Piperidine-piperazine ligands for neurotransmitter receptorsSEPRACOR INC·Filed 2004·Granted Aug 30, 2005·3 cites·20 claims
- 3171US5476851APyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1994·Granted Dec 19, 1995·25 cites·24 claims
- 3268US5597837AMethod and composition for treating psoriasis with styryl-substituted pyridyl compoundsRH & E CIR O & EE NE POULENC R·Filed 1994·Granted Jan 28, 1997·8 cites·6 claims
- 3366US7087623B2Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2004·Granted Aug 8, 2006·2 cites·20 claims
- 3463US6548637B1Ligands for opioid receptorsSEPRACOR INC·Filed 1999·Granted Apr 15, 2003·17 cites·79 claims
- 3562US7446115B2Peptidomimetic ligands for cellular receptors and ion channelsSEPRACOR INC·Filed 2006·Granted Nov 4, 2008·0 cites·5 claims
- 3659US7550597B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2005·Granted Jun 23, 2009·0 cites·6 claims
- 3759US2006194785A1Spirocyclic ligands for sigma receptors, and libraries and methods of use thereofRADEKE HEIKE·Filed 2006·Application pending·0 cites
- 3847US7115664B2Peptidomimetic ligands for cellular receptors and ion channelsSEPRACOR INC·Filed 2001·Granted Oct 3, 2006·0 cites·7 claims
- 3947US2004014774A1Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinaseFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →